SUBSCRIBE
SUBSCRIBE

Phase 2

Exiting Novartis AG CEO Sets His Sights on Silicon Valley and Its Biotech Startups
Drug Development
Novartis AG Lays Out R&D Game Plan at Meet and Greet With 30 Execs in Boston
June 1, 2017
 · 
3 min read
Gilead Suffers Another R&D Setback as Myelofibrosis Drug Flops in Phase III, Gives Credence to Acquisition Urgency
Drug Development
A Look at Gilead’s Possible New Drug Strategy
May 31, 2017
 · 
3 min read
Antares Pharma Implodes After FDA Responds to Its Xyosted NDA
Drug Development
How Much Juno Spent on Its Failed CAR-T Drug
May 26, 2017
 · 
2 min read
Wall Street's Top Biotech Analyst Loves These 2 Life Science Stocks
Drug Development
Biocryst Stock Caught Fire After Reporting Positive Phase II HAE Data
May 26, 2017
 · 
2 min read
3 Biotechs That Could be Taken Out This Quarter
Drug Development
5 Big Pharmas Facing Catalysts in 2017
May 25, 2017
 · 
3 min read
Massachusetts' Biostage Slashes 71% of Staff, Evaluating Strategic Alternatives
Drug Development
Neurocrine Tanks as Tourette Syndrome Drug Flunks Mid-Stage Study
May 24, 2017
 · 
2 min read
Drug Development
Why This Struggling Socal Biotech Could Be The Next Big Marijuana Stock
May 23, 2017
 · 
1 min read
Biotech Vets Launch Arrakis With $38 Million and Will be Helmed By Biogen Alum Michael Gilman
Drug Development
6 (Plus 2!) Most Notable ASCO Abstracts So Far
May 22, 2017
 · 
3 min read
Biotech Vets Launch Arrakis With $38 Million and Will be Helmed By Biogen Alum Michael Gilman
Drug Development
5 Biotechs Releasing Highly-Anticipated Data at ASCO
May 19, 2017
 · 
2 min read
Massachusetts' Biostage Slashes 71% of Staff, Evaluating Strategic Alternatives
Drug Development
GlycoMimetics Stock Takes Off on Positive Phase II Leukemia Data, Breakthrough Tag
May 18, 2017
 · 
3 min read
Load More
PRESS RELEASES
Press Releases
Bausch + Lomb Announces Phase 2 Results for Glaucoma Neuroprotective Candidate
July 10, 2026
 · 
4 min read
Press Releases
LEO Pharma Announces Key Results of Phase 2 TRAPEDS-1 Trial Evaluating Pharmacokinetics and Safety of Tralokinumab in Children With Moderate-to-Severe Atopic Dermatitis
July 9, 2026
 · 
6 min read
Press Releases
Delcath Systems Announces First Patient Dosed in Phase 2 Clinical Trial of HEPZATO™ in Liver-Dominant Metastatic Breast Cancer
July 9, 2026
 · 
4 min read
Press Releases
Quoin Pharmaceuticals Receives FDA IND Clearance to Initiate Phase 2 Study of QRX003 in Peeling Skin Syndrome
July 9, 2026
 · 
7 min read
Press Releases
CervoMed Announces Completion of Enrollment in Phase 2 Study of Neflamapimod for Nonfluent Variant Primary Progressive Aphasia, a Type of Frontotemporal Dementia
July 9, 2026
 · 
9 min read
Press Releases
Opus Genetics Provides BEST1 Program Update with Detailed Timeline for OPGx-BEST1 Results
July 9, 2026
 · 
7 min read
Press Releases
INmune Bio to Present Positive Phase 2 Imaging Data for XPro in Early Alzheimer’s Disease at AAIC
July 9, 2026
 · 
6 min read
Press Releases
Lynk Pharmaceuticals Announces First Patient Dosed in Phase II Clinical Trial of LNK01004 Ointment for Vitiligo
July 9, 2026
 · 
3 min read
Press Releases
MAIA Biotechnology Reports Strong Initial Efficacy Data in Third-Line Non-Small Cell Lung Cancer from Phase 2 THIO-101 Part C Expansion Trial
July 8, 2026
 · 
6 min read
Press Releases
Vaccinex to Report New Biomarker Data and Plans for Phase 2B Clinical Trial of Pepinemab in AD at the Alzheimer’s Association International Conference in London on July 13, 2026
July 8, 2026
 · 
6 min read
Press Releases
Chemomab Therapeutics and Precision Medicine Pioneer Scipher Medicine Announce Merger Agreement to Advance Nebokitug in an AI-Powered Phase 2 Trial in Rheumatoid Arthritis
July 8, 2026
 · 
21 min read
Press Releases
Eradivir Doses First Influenza Patient With EV25 in Bangladesh Study
July 7, 2026
 · 
3 min read
Press Releases
Kenai Therapeutics Announces Completion of Enrollment in Phase 1b/2a REPLACE™ Trial of RNDP-001 in Idiopathic Parkinson’s Disease
July 7, 2026
 · 
4 min read
Press Releases
FibroBiologics Completes Manufacturing of Third Batch of CYWC628 Drug Product for Phase 1/2 Diabetic Foot Ulcer Clinical Trial
July 7, 2026
 · 
5 min read
Press Releases
Oragenics Achieves Full Activation of Australian Phase IIa Trial Network — All Three Sites Now Enrolling
July 7, 2026
 · 
4 min read
Press Releases
Turn Therapeutics Announces Final Stage 2 Design and Data-Driven Expansion of GX-03 Phase 2 Program in Atopic Dermatitis
July 7, 2026
 · 
10 min read
Press Releases
Allarity Therapeutics Announces CLIA Certification, Clearing the Path for Advancing DRP® Testing for FDA Registration
July 7, 2026
 · 
9 min read
Press Releases
Theriva™ Biologics Announces Regulatory Authorization to Proceed with a VIRAGE2 Phase 2a Clinical Trial to Evaluate More Frequent Dosing of VCN-01 (zabilugene almadenorepvec) in First-Line Patients with Metastatic Pancreatic Ductal Adenocarcinoma
July 7, 2026
 · 
10 min read
Press Releases
CoRegen, Inc. Receives FDA Clearance to Advance CRG-150 into Phase 1/2a Clinical Trials, Pioneering a New Frontier in Cell Therapy for Multiple Solid Tumor Types
July 7, 2026
 · 
4 min read
Press Releases
Vivani Medical Enters into Agreement with Novo Nordisk to Evaluate NPM-139, a Miniature, Ultra Long-Acting Semaglutide Implant for Chronic Weight Management
July 7, 2026
 · 
4 min read
Load More